IL4 and Increased total eosinophil count: Therefore, because of the reduction in nasal mucosa eosinophilia, IL-4 and IL-5 levels in NLF, and OVA-specific IgE levels in sera, 2ME2 treatment likely inhibits the nasal allergic responses.